Main text

Nowadays, there is an increasing trend in the isolation of Methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia and plenty of questions regarding the best therapy to treat this kind of condition [1, 2]. According to this, we have carefully read the very recent article written by Shi et al. [3] which tries to respond the previous question, however we have found different flaws that prevent the generalization of these results.

The following are a few issues to be considered: 1. The search strategy is not presented in reproducible way, as it is described in Cochrane manual and other methodological strategies [4]. Besides, three elements are the most important to construct it: Population, Intervention and type of study [5]. On the contrary, the items shown were: Population, intervention, control and outcome, which might explain the limited number of articles found; 2. There are different strategies to saturate information in systematic reviews, however these were not shown here (P.e. Grey literature databases, clinical trial registries, thesis databases, google scholar, among others); 3.Regarding the Sensitivity analysis, authors explain that they excluded each publication, nonetheless they do not report the new results excluding the most weighted study (McDanel 2017; 81.5%) in the general analysis.

As we previously said, these important flaws, might lead to selection, publication and information bias that prevent the generalization and application of these results. Therefore, we might take them very carefully in our clinical practice.

Response to: “Interventions to treat Methicillin-susceptible Staphylococcus aureus bacteremia: Many methodological concerns”

  • Changcheng Shi,
  • Fei Teng &
  • Nengming Lin 

  1. Department of Clinical Pharmacy, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China

    Changcheng Shi & Nengming Lin

  2. College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China

    Fei Teng

  3. Department of Clinical Pharmacy, Hangzhou First People’s Hospital, Nanjing Medical University, Hangzhou, China

    Nengming Lin

  4. Department of Clinical Pharmacology, Translational Medicine Research Center, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China

    Nengming Lin

Changcheng Shi and Fei Teng contributed equally to this work

We thank Garcia-Perdomo HA and Maldonado JFT for their interest in our work [3]. The responds to the comments are as following:

  1. 1.

    We consider that the following three elements are required to ensure the repeatability of the search strategy: a) lists of databases, b) full search terms, and c) limitations on publication date. These three elements have been presented in our meta-analysis. Therefore, the search results of our meta-analysis are reproducible, to some extent. We agree that putting the full search strategies for each database into an Appendix may be better, as it is recommended by Cochrane Collaboration [4]. The full search strategies are described in Additional file 1: Tables S1-S3.

    We agree that it is usually unnecessary to search on every aspect of the review’s clinical question (often referred to as PICO – that is Population, Intervention, Comparison and Outcome). In our meta-analysis, three elements (Population, Intervention and Comparison) were used as the search terms but not all the elements of PICO as Garcia-Perdomo HA and Maldonado JFT pointed out. Considering the Outcome may not be well described and are often not well indexed with controlled vocabulary terms, we did not use the search terms relating to Outcome. Types of study is important (typically a ‘filter’ for randomized trials) [4]. However, both randomized trials and observational studies met the criteria of our meta-analysis. Therefore, we did not use the terms relating to type of study.

  2. 2.

    Regarding the database, it is recommended by Cochrane Collaboration that CENTRAL and MEDLINE should be searched, as a minimum, together with EMBASE if it is available to the review author [4]. CENTRAL is published as part of The Cochrane Library. PubMed provides access to a free version of MEDLINE that also includes up-to-date citations not have been indexed for MEDLINE yet. Therefore, we think our choice of database (PubMed, EMBASE and the Cochrane Library) is acceptable. We agree that searching more databases may be beneficial, but the other factors (e.g. time spending and budget considerations) need to be balance.

  3. 3.

    We have performed a sensitivity analysis to evaluate the stability of our meta-analysis by excluding the study by McDanel et al. [6] and no inconsistency results were revealed (OR, 0.56; 95% CI, 0.37 to 0.84; I2 = 1.6%). In fact, the data have been shown in our publication (Additional file 1: Table S3) [3].

    We agree that meta-analysis require a thorough, objective and reproducible search of a range of sources to identify as many relevant studies as possible to minimize bias.

    Once again, thank Garcia-Perdomo HA and Maldonado JFT for their comments and suggestions.